Is it time to renew your membership? The RIC is pleased to thank each one of our members for your continued support of our mission to fosters collaboration and innovation to advance patient safety. If it is time for you to renew, we would like to remind you to visit our website and renew your membership today! https://lnkd.in/eTfYMdzX
REMS Industry Consortium
制药业
Mt Laurel，New Jersey 895 位关注者
Innovating Patient Safety. Mitigating Risk.
关于我们
The REMS Industry Consortium, Inc. (RIC) is a nonprofit organization representing the perspectives of organizations that sell, or anticipate selling, prescription drugs or biologics subject to Risk Evaluation and Mitigation Strategies (REMS). Through its mission, RIC fosters collaboration and innovation to advance patient safety, develops best practices, works to solve industry issues and more. Additionally, the RIC works to: ? Foster and encourage two-way communication between Manufacturer/REMS sponsors and FDA ? Discuss and clarify challenges faced by industry sponsors and FDA ? Establish best practices for REMS throughout the development, review, and management lifecycle ? Provide FDA with a "sounding board" to solicit feedback on REMS ? Collectively explore expectations for vendors, including participation and capabilities in REMS Please visit REMSconsortium.org to learn more about RIC.
- 网站
-
https://remsconsortium.org/
REMS Industry Consortium的外部链接
- 所属行业
- 制药业
- 规模
- 1 人
- 总部
- Mt Laurel，New Jersey
- 类型
- 非营利机构
- 创立
- 2021
- 领域
- Risk Evaluation and Mitigation Strategies (REMS)
地点
-
主要
获取路线
1120 NJ-73 #200
US，New Jersey，Mt Laurel，08054
REMS Industry Consortium员工
动态
-
RIC members have the opportunity to collaborate with REMS professionals on resources and innovations that advance our collective vision of improving patient safety. The RIC hosts an annual two-day event designed to connect REMS professionals, fostering knowledge sharing and personal connections. Visit the RIC website to learn more about member benefits! Join now! https://ow.ly/YZ8150U3iEU
-
-
We are proud to highlight Apotex as a member of the RIC! Founded in 1974, Apotex is a Canadian global pharmaceutical company that strives to improve access to medicine and health products worldwide. Thank you for being a member! Collaborate with REMS professionals on resources and innovations that advance our collective vision of improving patient safety. Become a member of the RIC today! See membership benefits: ??https://ow.ly/IOJj50U3irh
-
-
The World Drug Safety Congress Americas 2024 is now only days away! Our team looks forward to connecting with fellow REMS professionals, next week on October 29-30, 2024 at the Boston Convention and Exhibition Center in Boston, MA. Stop by our exhibit booth 333! Don't miss this exclusive offer: RIC Members receive a 50% discounted rate. Members should reach out to [email protected] if interested. Learn more: https://lnkd.in/dZPJ9Yj
-
-
The FDA is hosting a virtual meeting on "Putting the Pieces Together: REMS Logic Model in REMS Design, Implementation, and Evaluation" on November 7th from 1:00 pm to 2:30 pm Eastern. For more information, please visit the FDA website. https://lnkd.in/d_AT3a9s
-
Drug, Biologic, and Medical Device Attorney and Regulatory Strategist
I’m so pleased to have joined members of the REMS Industry Consortium for their meeting with FDA. Buchanan Ingersoll & Rooney PC has been a strategic partner to the RIC since the inception and we are honored to work with and support such distinguished pharma professionals to help the RIC advance its mission. Looking forward to great things in the future!
Head, Risk Management (REMS) and U.S. Pharmacovigilance at J&J Innovative Medicine; Board Chair and Founder, REMS Industry Consortium
Leaders from the REMS Industry Consortium met with some of our key counterparts at the FDA to talk about the current state of REMS, and the future of patient risk management - what a great meeting! Big thank you to our members for the great work we’re doing to advance patient safety! Thanks for making the trip and for your incredible expertise Barbara Binzak Blumenfeld, PhD, Esq., Jamie Wilkins, Kal Elhoregy, R. Ph., PA., Kishore Gopu, Ronald Selders, Michael Cheung, and Shilpa Patil!
-
-
Head, Risk Management (REMS) and U.S. Pharmacovigilance at J&J Innovative Medicine; Board Chair and Founder, REMS Industry Consortium
Leaders from the REMS Industry Consortium met with some of our key counterparts at the FDA to talk about the current state of REMS, and the future of patient risk management - what a great meeting! Big thank you to our members for the great work we’re doing to advance patient safety! Thanks for making the trip and for your incredible expertise Barbara Binzak Blumenfeld, PhD, Esq., Jamie Wilkins, Kal Elhoregy, R. Ph., PA., Kishore Gopu, Ronald Selders, Michael Cheung, and Shilpa Patil!
-
-
We invite you to learn something new or refresh your #REMS knowledge with the RIC's resource library! Check it out now: https://lnkd.in/eG3Nyx92 Want more? Get involved with the RIC as a member today. New and current members should join a working group and check out the members-only portal for all the ways to expand your participation. https://lnkd.in/ett8C4SB
-
-
?? Only 2 weeks until the World Drug Safety Congress Americas 2024! Don't forget to visit the REMS Industry Consortium (RIC) at our stall. Explore cutting-edge strategies in data management and signal detection. See you on October 29-30! Get your tickets today: https://lnkd.in/eGD7F2MP RIC members receive a 50% discount to register. Contact us now for the code! https://lnkd.in/ehf4cFcE #WorldDrugSafety
-
-
Shape the RIC voice and help us expand our reach! The Communication & Marketing Working Group is working hard to enrich and expand RIC's membership through personal outreach to potential members and current members. They are also reviewing available marketing resources to ensure messages stay relevant and further broaden RIC's reach in the REMS community. Sound interesting? Join this RIC Working Group today and help make a difference in the REMS landscape. https://lnkd.in/eHgSPUWe
-